ArticleScientific reports2026
Impact of post-transfusion hemoglobin levels on survival in critically Ill patients: a machine learning-based causal inference analysis.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Restrictive red blood cell transfusion strategies (hemoglobin trigger 7.0–8.0 g/dL) are well established, yet existing evidence addresses primarily when to initiate transfusion. The optimal achieved post-transfusion hemoglobin level in critically ill patients with severe anemia (pre-transfusion hemoglobin ≤ 8.0 g/dL) remains unknown. We analyzed 3,710 intensive care unit admissions in the Medical Information Mart for Intensive Care IV (MIMIC-IV; 3,339 training, 371 test) and externally validated findings in 4,719 admissions from the eICU Collaborative Research Database. Eligible subjects received red blood cells within 48 h of ICU admission, had a pre-transfusion hemoglobin ≤ 8.0 g/dL, and had no additional transfusions between 48 h and seven days. Using a double machine learning causal forest, we estimated treatment effects for post-transfusion hemoglobin targets from 8.0 to 14.0 g/dL relative to 8.0 g/dL, identified the target with the lowest predicted in-hospital mortality, evaluated subgroups, and modeled predictors of targets below 10.0 g/dL. Dose–response curves were U-shaped in all datasets. The estimated optimal hemoglobin was 11.0 g/dL in the training set, 10.9 g/dL in the test set, and 11.0 g/dL in external validation. Estimated optimal levels near 11.0 g/dL were consistent across chronic kidney disease, end-stage kidney disease, myocardial infarction, congestive heart failure, hypertension, and diabetes. Lower baseline hemoglobin and lower estimated glomerular filtration rate were associated with lower individualized optimal levels. Indicators of inflammation or hemodynamic instability, including hypotension, fever, leukocytosis, hyperlactatemia, acidosis, and vasopressor requirements, were associated with estimated optimal achieved post-transfusion hemoglobin levels below 10.0 g/dL. Among ICU subjects transfused under a restrictive trigger (hemoglobin ≤ 8.0 g/dL), an achieved post-transfusion hemoglobin around 11.0 g/dL was associated with the lowest predicted in-hospital mortality.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.